CARE-DNA IP
PrivateLast Round
Accelerator
Aug 28, 2025
Total Funding Raised
$3.49M
Company Overview
CARE-DNA IP is a biotechnology company that provides a non-invasive screening solution for the early detection of pancreatic cancer and other hard-to-detect cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CARE-DNA IP Comparables
Compare CARE-DNA IP with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Procyon Diagnostics | 82% | |
| Pharus Diagnostics | 79% | |
| Singlera Genomics Inc. | 77% | |
CARE-DNA IP Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 28, 2025 | ||||
| Grant | Apr 24, 2025 | ||||
| Grant | Apr 9, 2025 |
Key People
Founding team and executive leadership
CARE-DNA IP Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Danish Tech Challenge | Grant |
| BioInnovation Institute | Accelerator |
CARE-DNA IP Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CARE-DNA IP's valuation, stock price, and market status.